COVID-19 severity among patients with multiple sclerosis treated with cladribine: A systematic review and meta-analysis
Author:
Publisher
Elsevier BV
Subject
Neurology (clinical),Neurology,General Medicine
Reference26 articles.
1. Risk of getting COVID-19 in people with multiple sclerosis: a case-control study;Iaffaldano;Neurol. Neuroimmunol. Neuroinflamm.,2022
2. COVID-19 vaccination in fragile patients: current evidence and an harmonized transdisease trial;Agrati;Front. Immunol.,2021
3. Prevalence of SARS-CoV-2 antibodies in multiple sclerosis: the hidden part of the iceberg;Capasso;J. Clin. Med.,2020
4. COVID-19 and disease-modifying therapies in patients with demyelinating diseases of the central nervous system: a systematic review;Sharifian-Dorche;Mult. Scler. Relat. Disord.,2021
5. COVID-19 in patients with multiple sclerosis undergoing disease-modifying treatments;Laroni;Mult. Scler.,2021
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Cladribine Tablets Mode of Action, Learning from the Pandemic: A Narrative Review;Neurology and Therapy;2023-07-08
2. Expert Narrative Review of the Safety of Cladribine Tablets for the Management of Relapsing Multiple Sclerosis;Neurology and Therapy;2023-06-29
3. Safety and efficacy of cladribine in multiple sclerosis: a systematic review and meta-analysis;Neurological Sciences;2023-04-17
4. Navigating the landscape of COVID-19 for Multiple Sclerosis patients and clinicians;Neurologia i Neurochirurgia Polska;2023-02-28
5. Multiple sclerosis patients treated with cladribine tablets: expert opinion on practical management after year 4;Therapeutic Advances in Neurological Disorders;2023-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3